))
Episode 15: FDA Regulations on Compounded Peptides: with Dr. Wade McKenna and Mike Mitchell
Manage episode 381679449 series 3525476
Content provided by RNCN. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by RNCN or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In Episode 15 of our YouTube podcast series, we dive deep into the fascinating world of peptide therapy and the FDA's role in regulating these powerful compounds. Join us as we host two prominent experts, Dr. Wade McKenna and Mike Mitchell, to unravel the complex web of safety concerns, motivations, and the future of peptide drugs.
Peptide therapy has gained significant attention for its potential in addressing a wide range of health issues, from anti-aging solutions to performance enhancement. However, as the popularity of peptides has soared, so have questions surrounding their safety and regulation.
Dr. Wade McKenna, a leading figure in the field of regenerative medicine & peptide therapy, shares insights into the real concerns regarding the regulation of the use and administration of peptides. Mike Mitchell, a seasoned expert in pharmaceuticals and FDA policy, sheds light on the FDA's evolving stance on peptides and the potential motives behind their regulatory efforts.
In this thought-provoking conversation, we aim to demystify the FDA's involvement, explore the genuine safety issues surrounding peptides, and uncover the true intentions behind FDA regulations. Join us for an engaging and informative discussion that will leave you with a better understanding of the peptide therapy landscape and its future. Whether you're a healthcare professional, a researcher, or simply curious about this cutting-edge field, Episode 15 is not to be missed. Subscribe, like, and share to stay informed about the latest developments in the world of peptide drugs!
…
continue reading
Peptide therapy has gained significant attention for its potential in addressing a wide range of health issues, from anti-aging solutions to performance enhancement. However, as the popularity of peptides has soared, so have questions surrounding their safety and regulation.
Dr. Wade McKenna, a leading figure in the field of regenerative medicine & peptide therapy, shares insights into the real concerns regarding the regulation of the use and administration of peptides. Mike Mitchell, a seasoned expert in pharmaceuticals and FDA policy, sheds light on the FDA's evolving stance on peptides and the potential motives behind their regulatory efforts.
In this thought-provoking conversation, we aim to demystify the FDA's involvement, explore the genuine safety issues surrounding peptides, and uncover the true intentions behind FDA regulations. Join us for an engaging and informative discussion that will leave you with a better understanding of the peptide therapy landscape and its future. Whether you're a healthcare professional, a researcher, or simply curious about this cutting-edge field, Episode 15 is not to be missed. Subscribe, like, and share to stay informed about the latest developments in the world of peptide drugs!
26 episodes
Share
